Health Trials

Genital Psoriasis

2

Review clinical trials related to Genital Psoriasis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO)

The main aim of this study is to check the safety and effectiveness of tildrakizumab regarding the alleviation of symptoms in the genital area after administration according to the summary of product characteristics (SmPC) and to access overall treatment safety and quality of life assessed on multiple scales.

Participants needed: 110
Trial details
Age: 18-99Biological sex: AllType: ObservationalSponsor: Almirall, S.A.Updated: Jan 29, 2025Locations: 1
Eligibility criteria

Confirmed diagnosis of psoriasis, with significant involvement of genital region... [+5]

Patient appears to be unwilling or unable to comply with the requirements of the... [+4]

Read more
Status: Not yet recruiting

Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real)

Xeligekimab Injection was approved in China on August 20, 2024, for treating adults with moderate to severe plaque psoriasis who are candidates for systemic treatment or phototherapy. Despite the promising efficacy and safety shown in the phase III clinical trial, real-world data is needed to further support clinical decisions for this patient group. This study aims to evaluate the effectiveness and safety of xeligekimab in real-world clinical settings for adults with moderate to severe plaque psoriasis.

Participants needed: 1,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Chongqing Genrix Biopharmaceutical Co., LtdUpdated: Jan 31, 2025Locations: 1
Eligibility criteria

Patients 18 years of age or older; [+3]

Patients with drug-induced psoriasis (such as new-onset or exacerbated psoriasis... [+4]

Read more